208 related articles for article (PubMed ID: 21455631)
1. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
3. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
Yuan LW; Liu DC; Yang ZL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Lv F; Yang ZL; Miao XY
Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
[TBL] [Abstract][Full Text] [Related]
8. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.
Yang L; Lan S; Liu J; Yang Z
Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336
[TBL] [Abstract][Full Text] [Related]
9. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder.
Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X
World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496
[TBL] [Abstract][Full Text] [Related]
11. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
Xiong L; Deng X; Wen Y; Yang Z; Miao X
World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
[TBL] [Abstract][Full Text] [Related]
12. Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Jiang S; Miao XY
Tumour Biol; 2012 Feb; 33(1):173-82. PubMed ID: 22076922
[TBL] [Abstract][Full Text] [Related]
13. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766
[TBL] [Abstract][Full Text] [Related]
14. [Expression of enhancer of zesle homolog 2 and phosphatase and tension homolog and its clinicopathological significance in benign and malignant lesion of gallbladder].
Liu DC; Yang ZL; Yang LP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):618-22. PubMed ID: 18667776
[TBL] [Abstract][Full Text] [Related]
15. PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.
Zou Q; Yang L; Yang Z; Huang J; Fu X
Biomed Res Int; 2013; 2013():648420. PubMed ID: 23984394
[TBL] [Abstract][Full Text] [Related]
16. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
Liu DC; Yang ZL
Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
18. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
Xiong L; Yang Z; Yang L; Liu J; Miao X
J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance.
Cai W; Li Q; Yang Z; Miao X; Wen Y; Huang S; Ouyang J
Clin Transl Oncol; 2013 Oct; 15(10):818-24. PubMed ID: 23475628
[TBL] [Abstract][Full Text] [Related]
20. TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Liu D; Li D; Zou Q; Yuan Y; Li J; Liang L; Chen M; Chen S
Oncol Lett; 2014 Apr; 7(4):1128-1138. PubMed ID: 24944680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]